Stephen D. Nimer, M.D., named Mentor of the Year by the American Society of Hematology
Stephen D. Nimer, M.D., has been awarded the American Society of Hematology’s (ASH) Mentor Award for 2024. As director of Sylvester Comprehensive Cancer Center, Nimer is known for lifting up and guiding other researchers to create a collaborative environment that drives scientific discovery and quality patient care.
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces an oral presentation and three poster presentations at the American Society of Hematology (ASH) Annual Meeting,
Two researchers from Huntsman Cancer Institute at the University of Utah (the U) have discovered a gene variant found in high ...
Data from Eli Lilly and AstraZeneca could help doctors decide treatment order in chronic lymphocytic leukemia. Elsewhere, ...
SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a ...
Patients with multiple myeloma are living longer, thanks to a host of new immunotherapies and targeted drugs. But there is ...
presented new investigational combination data in an oral presentation at the 2024 American Society of Hematology (ASH) Meeting in San Diego, CA. Data from the investigator-sponsored study were ...
Rasika Venkataraman, a third-year doctoral student working in the lab of Stanley C. Lee, PhD, at Fred Hutch Cancer Center, ...
today announced it will present new data on its novel gene delivery platform and therapeutic programs at the 66 th American Society of Hematology (ASH) Annual Meeting and Exposition, being held ...
Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen ...
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s ...
Hoffmann-La Roche Ltd, Horiba Ltd., Neomedica, Thermo Fisher Scientific, Agilent, and several others, are currently operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback